FreeCast surges premarket; Accenture, Novocure slide
Investing.com - U.S. stock futures ticked higher on Thursday, as the signing of an interim Middle East peace deal helped ease concerns sparked by the Federal Reserve’s hawkish policy outlook.
By 0750 ET (11:50 GMT), the Dow futures contract had risen 0.12%, S&P 500 futures had gained 0.7%, and Nasdaq 100 futures had jumped 1.24%.
Technology stocks were among the strongest performers in premarket trading, while investors also reacted to earnings-related updates, executive changes and healthcare developments.
Here are some of the biggest premarket U.S. stock movers today:
Accenture plc (NYSE: ACN) tumbled more than 11% after the consulting giant trimmed the upper end of its annual revenue growth forecast, signaling that clients remain cautious about spending on discretionary technology consulting projects. The company also announced a series of cybersecurity acquisitions, including a majority stake in Dragos.
Pfizer Inc (NYSE: PFE) slipped 1.7% after the drugmaker announced that Chief Financial Officer Dave Denton will step down and leave the company in August to pursue an opportunity outside the pharmaceutical industry.
Oklo Inc (NYSE: OKLO) rose 2% after the advanced nuclear technology company signed a letter of intent with Centrus Energy for the future supply of high-assay low-enriched uranium to support its planned Aurora powerhouse deployment in Ohio. Deliveries are expected to begin in 2029.
Freecast Inc A (NASDAQ: CAST) shares surged 170% after the company announced a reseller agreement for Starlink Business services. The deal allows FreeCast to offer enterprise satellite broadband connectivity alongside its streaming media and platform services.
Novocure Ltd (NASDAQ: NVCR) fell 10% after reporting that its Phase 3 TRIDENT study failed to meet its primary endpoint of improving overall survival in patients with newly diagnosed glioblastoma.
